The effects of IMMUTONIC capsule oral three times daily for 1 week on volunteers with flu symptoms, their blood immune parameters and CD4 T-cells

The effects of IMMUTONIC capsule oral three times daily for 1 week on volunteers with influenza symptoms, their blood immune parameters and CD4 T-lymphocytes: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN49673328

Enrollment

Registered

2020-12-29

Start date

2020-04-01

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza symptoms Infections and Infestations

Interventions

Twenty-four male and female adult volunteers, aged between 21 and 60 years are selected for the study. The volunteers are free from significant cardiac, hepatic, renal, pulmonary, gastrointestinal, ne

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female adult volunteers, aged between 21 and 60 years, with flu symptoms 2. Free from significant cardiac, hepatic, renal, pulmonary, gastrointestinal, neurological or hematological disease as determined by way of medical histories, physical examinations

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Flu symptoms assessed using improving health scale (0-5) before and 3 and 7 days after treatment	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Yemen

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026